Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 1—January 2012

Cutaneous Leishmaniasis Acquired in Jura, France

On This Page
Article Metrics
citations of this article
EID Journal Metrics on Scopus

Cite This Article

To the Editor: Cutaneous leishmaniasis is well established in the Mediterranean basin. However, the disease is spreading and new foci have been reported (13). Because of climate change, it is feasible that vector-borne diseases such as cutaneous leishmaniasis may spread northward into Europe (4). We report a patient who acquired cutaneous leishmaniasis while on holiday in Jura, France.

A previously healthy 49-year-old white man from the Netherlands traveled to France in August 2007. During August 2–17, he stayed at a camp site in Clairvaux-les-Lacs in a forested area near a lake. He made regular trips by foot in the surrounding area. Three months later, he noticed a swelling on his nose. In February 2008, he consulted a dermatologist who treated him twice with cryotherapy under a diagnosis of actinic keratosis, after which the lesion nearly disappeared.

Three months later, the patient again consulted the dermatologist when the lesion recurred. A biopsy result from the lesion was interpreted as an acute ulcerative inflammation without further specification. Treatment was continued with imiquimod 5% cream followed by erythromycin 2% cream with clobetasol 0.05% ointment. Because of a lack of improvement, this treatment regimen was alternated with tacrolimus 0.1% ointment until May 2008.


Figure. A) Crustosus plaque on the nose of the patient. B) The epidermis shows parakeratosis, atrophy, and a single apoptotic keratinocyte. An inflammatory infiltrate is present in the papillary dermis, mainly composed...

In November 2008, he consulted another dermatologist, who obtained a biopsy specimen in which a large number of intracellular microorganisms compatible with leishmaniasis were observed in histiocytes. The patient was then referred to the Department of Dermatology at the Academic Medical Centre in Amsterdam. On examination, we found a plaque with a crusting surface and an erythematous border on the bridge of the nose (Figure, panel A). Regional lymph nodes were not palpable.

Revised histopathologic examination of the biopsy specimen showed a dermal inflammatory infiltrate of histiocytes containing numerous intracellular Leishmania amastigotes and epithelioid cells, lymphocytes, and few plasma cells (Figure, panel B). A direct smear from the biopsy specimen was positive for Leishman-Donovan bodies. Culture on Novy-MacNeal-Nicolle medium was positive for Leishmania spp. A PCR result for Leishmania performed on a biopsy specimen from the lesion was positive; sequence analysis showed DNA of Leishmania donovani/infantum complex.

Treatment was initiated with oral itraconazole (100 mg, 2×/d) for 6 weeks without improvement and was then continued with miltefosine (50 mg 3×/d) for 28 days. Other than nausea, the patient did not experience side effects. Regular monitoring of liver function showed values within normal limits. The lesion healed completely.

There are several reports of leishmaniasis acquired in Europe in locations north of the Mediterranean basin. Naucke et al. (5) reported 11 cases of endemically acquired leishmaniasis (human, canine, feline, and equine infections) in Germany since 1991. In 1992, a child with visceral leishmaniasis was described who had spent weekends and holidays near Calais, France (6).

We assume that our patient acquired cutaneous leishmaniasis in mainland Europe at 46°N. He had not visited Leishmaniasis-endemic areas before this holiday in the French Jura.

Cutaneous leishmaniasis in France is found mainly in the region Pyrénées-Orientales, with 2 sandflies, Phlebotomus ariasi and Phlebotomus perniciosus, as vectors (7). One of the causative factors for the northward emergence of leishmaniasis in Europe is the spread of visceral and cutaneous leishmaniasis from disease-endemic areas in the Mediterranean to neighboring temperate areas with vectors without disease (8). A northward spread of leishmaniasis with an extension of the geographic range of Ph. perniciosus and Ph. neglectusus sandflies has been found in Italy (9), and northward spread of the proven sanfly vector Ph. (Laroussius) perniciosus and the competent sandfly vector Ph. (Transphlebotomus) mascittii into Germany (5). It has been hypothesized that sandflies have always been sporadically present in central Europe, but that climate change will lead to extended distribution (10).

It is tempting to assume that climate change resulted in cutaneous leishmaniasis at 46°N in France. In any event, our case and those reported by others should make clinicians aware of the possibility of cutaneous leishmaniasis outside the well-known disease-endemic areas.


William R. FaberComments to Author , Rick Hoekzema, Aldert Bart, Jim E. Zeegelaar, and Henry J.C. de Vries
Author affiliations: Academic Medical Centre, Amsterdam, the Netherlands



  1. Rhajaoui  M, Nasereddin  A, Fellah  H, Azmi  K, Amarir  F, Al-Jawabreh  A, New clinico-epidemiologic profile of cutaneous leishmaniasis, Morocco. Emerg Infect Dis. 2007;13:135860.PubMedGoogle Scholar
  2. Antoniou  M, Haralambous  C, Mazeris  A, Pratlong  F, Dedet  JP, Soteriadou  K. Leishmania donovani leishmaniasis in Cyprus. Lancet Infect Dis. 2008;8:67. DOIPubMedGoogle Scholar
  3. World Health Organization. Control of the leishmaniases: report of a meeting of the WHO expert committee on the control of leishmaniases. Geneva, 22–26 March 2010 [cited 2011 Oct 27].
  4. Watson  RT, Patz  J, Gubler  DJ, Parson  EA, Vincent  JH. Environmental health implications of global climate change. J Environ Monit. 2005;7:83443. DOIPubMedGoogle Scholar
  5. Naucke  TJ, Menn  B, Massberg  D, Lorentz  S. Sandflies and leishmaniasis in Germany. Parasitol Res. 2008;103(Suppl 1):S658. DOIPubMedGoogle Scholar
  6. Mattot  M, Ninane  J, Bigaignon  G, Vermylen  C, Cornu  G. Visceral and cutaneous leishmaniasis in an European paediatric population. Acta Clin Belg. 1992;47:2317.PubMedGoogle Scholar
  7. Pratlong  F, Rioux  JA, Marty  P, Faraut-Gambarelli  F, Dereure  J, Lanotte  G, Isoenzymatic analysis of 712 strains of Leishmania infantum in the south of France and relationship of enzymatic polymorphism to clinical and epidemiological features. J Clin Microbiol. 2004;42:4077. DOIPubMedGoogle Scholar
  8. Ready  PD. Leishmaniasis emergence in Europe. Euro Surveill. 2010;15:19505.PubMedGoogle Scholar
  9. Maroli  M, Rossi  L, Baldelli  R, Capelli  G, Ferroglio  E, Genchi  C, L. The northward spread of leishmaniasis in Italy: evidence from retrospective and ongoing studies on the canine reservoir and phlebotomine vectors. Trop Med Int Health. 2008;13:25664. DOIPubMedGoogle Scholar
  10. Aspöck  H, Geresdorfer  T, Formayer  H, Walochnick  J. Sandflies and sandfly-borne infections of humans in central Europe in the light of climate change. Wien Klin Wochenschr. 2008;120(Suppl 4):249. DOIPubMedGoogle Scholar




Cite This Article

DOI: 10.3201/eid1801.110408

Related Links


Table of Contents – Volume 18, Number 1—January 2012

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

William R. Faber, Academic Medical Centre—Dermatology, Meibergdreef 9, Amsterdam 1105 AZ, Netherlands

Send To

10000 character(s) remaining.


Page created: December 20, 2011
Page updated: December 20, 2011
Page reviewed: December 20, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.